Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Johnson & Johnson announces opioid settlement with West Virginia

By Brian Buntz | April 18, 2022

Johnson & JohnsonJohnson & Johnson (NYSE:JNJ) has agreed to pay $99 million to put opioid-related claims in the State of West Virginia to bed. 

The state has removed J&J from an ongoing trial in Kanawha County. 

West Virginia’s attorney general, Patrick Morrisey, concluded that state’s decision not to join a nationwide settlement was worthwhile because the state received twice as much money from the state-based settlement than it would have otherwise received. The state would have received $48 million under the national settlement.

West Virginia will use the funds to support community efforts targeting the opioid crisis.  

The settlement did not include an admission of liability or wrongdoing. 

The settlement related to former sales of the drugs Duragesic (fentanyl transdermal system), Nucynta (tapentadol) and Nucynta ER, which 

West Virginia had accused Janssen, Teva and Allergan of violating state laws related to shipping opioids. 

In January, J&J announced similar deals with Colorado and Nevada.   

In 2015, Johnson & Johnson divested U.S. license rights for Nucynta-based products. 

The company permanently discontinued sales of Duragesic transdermal systems in 2020. 

JNJ shares were up 0.16% to $180.22 in morning trading.

West Virginia has an ongoing trial naming Teva Pharmaceuticals and Allergan.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Seagen
Seagen CEO Siegall resigns after domestic abuse arrest
Moderna
Moderna’s new CFO leaves after former employer discloses investigation
Pfizer logo
Pfizer to shell out $11.6B for migraine drugmaker Biohaven
Novartis logo
Novartis temporarily halts production of two radioligand therapy medicines

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards